[go: up one dir, main page]

DK1947104T3 - Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C - Google Patents

Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C

Info

Publication number
DK1947104T3
DK1947104T3 DK08000552.3T DK08000552T DK1947104T3 DK 1947104 T3 DK1947104 T3 DK 1947104T3 DK 08000552 T DK08000552 T DK 08000552T DK 1947104 T3 DK1947104 T3 DK 1947104T3
Authority
DK
Denmark
Prior art keywords
characterization
compositions
identification
methods
hcv
Prior art date
Application number
DK08000552.3T
Other languages
English (en)
Inventor
Carol Holland-Staley
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Application granted granted Critical
Publication of DK1947104T3 publication Critical patent/DK1947104T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK08000552.3T 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C DK1947104T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11
EP03714097A EP1490383B1 (en) 2002-03-11 2003-03-11 Methods and compositions for identifying and characterizing hepatitis c

Publications (1)

Publication Number Publication Date
DK1947104T3 true DK1947104T3 (da) 2012-08-06

Family

ID=28041784

Family Applications (3)

Application Number Title Priority Date Filing Date
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08014584.0T DK2014671T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C
DK08000552.3T DK1947104T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08014584.0T DK2014671T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C

Country Status (9)

Country Link
US (3) US20070172926A1 (da)
EP (3) EP1947104B1 (da)
AT (3) ATE423785T1 (da)
AU (2) AU2003218111B8 (da)
DE (2) DE60332781D1 (da)
DK (3) DK1490383T3 (da)
ES (3) ES2321498T3 (da)
PT (3) PT1947104E (da)
WO (1) WO2003077729A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE423785T1 (de) 2002-03-11 2009-03-15 Lab 21 Ltd Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c
US20080207760A1 (en) * 2005-04-11 2008-08-28 Achillion Pharmaceuticals, Inc. Pharmaceutical Compositions For and Methods of Inhibiting Hcv
EP1934598B1 (en) * 2005-10-14 2010-09-22 Ivan Mikhailovich Petyaev Diagnosis of obligate intracellular pathogens
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20080015787A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
US20080015834A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
EP2463389A1 (en) 2006-10-20 2012-06-13 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS5B genomic region
EP2527474A1 (en) 2006-10-20 2012-11-28 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS3/4A genomic region
CN101842498A (zh) * 2007-10-30 2010-09-22 英特芒尼公司 Hcv基因型分型和表型分型
EP2215272B1 (en) * 2007-10-31 2011-02-23 Debiopharm S.A. Near full-genome assay of hcv drug resistance
US20130244936A1 (en) 2010-06-04 2013-09-19 Vincent Goffin Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
WO2012177739A2 (en) 2011-06-20 2012-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting hcv
AU2013205064B2 (en) 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
IE62868B1 (en) 1987-11-18 1995-03-08 Chiron Corp Hepatitis C virus
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (en) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
ES2188583T3 (es) * 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
ATE551423T1 (de) * 1993-04-27 2012-04-15 Innogenetics Nv Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
WO1994025602A1 (en) * 1993-05-05 1994-11-10 Common Services Agency Hepatitis-c virus type 4, 5 and 6
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
AU8897698A (en) * 1997-07-30 1999-02-22 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
US20040137436A1 (en) * 2000-04-18 2004-07-15 Brendan Larder Method for measuring drug resistance
ATE525384T1 (de) * 2000-05-23 2011-10-15 Univ Washington Varianten des hepatitisvirus
EP1373576A4 (en) * 2000-07-24 2005-06-15 Inst Of Molecul & Cell Biology NUCLEIC ACIDS AND METHODS FOR DETECTING VIRAL INFECTIONS, DETECTING ANTI-VIRAL COMPOUNDS AND DETERMINING THE MEDICAMENT RESISTANCE OF VIRUSISOLATES
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
ATE423785T1 (de) 2002-03-11 2009-03-15 Lab 21 Ltd Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c

Also Published As

Publication number Publication date
PT1947104E (pt) 2012-08-09
DE60326327D1 (de) 2009-04-09
ATE423785T1 (de) 2009-03-15
AU2008249300B2 (en) 2012-08-16
DK1490383T3 (da) 2009-06-08
US20090047663A1 (en) 2009-02-19
PT1490383E (pt) 2009-05-25
EP1490383B1 (en) 2009-02-25
WO2003077729A2 (en) 2003-09-25
AU2003218111B2 (en) 2008-11-06
ES2346717T3 (es) 2010-10-19
WO2003077729A3 (en) 2004-06-03
EP1947104A3 (en) 2009-04-08
AU2003218111B8 (en) 2008-11-20
US20070172926A1 (en) 2007-07-26
EP2014671A1 (en) 2009-01-14
US20120322051A1 (en) 2012-12-20
AU2008249300A1 (en) 2008-12-18
DE60332781D1 (de) 2010-07-08
ATE556084T1 (de) 2012-05-15
WO2003077729A9 (en) 2004-04-22
EP1947104A2 (en) 2008-07-23
DK2014671T3 (da) 2010-09-20
US8173795B2 (en) 2012-05-08
AU2003218111A1 (en) 2003-09-29
EP1490383A4 (en) 2005-12-21
EP2014671B1 (en) 2010-05-26
ES2321498T3 (es) 2009-06-08
PT2014671E (pt) 2010-06-16
ES2386742T3 (es) 2012-08-28
EP1947104B1 (en) 2012-05-02
ATE469162T1 (de) 2010-06-15
EP1490383A2 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
DK1947104T3 (da) Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C
DE60233462D1 (de) Neue Zusammensetzung und Methode zur 'hot start' Nukleinsäureamplifizierung
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DK1026262T3 (da) Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf
DK1218542T3 (da) Fremgangsmåder og sammensætninger til lineær isotermisk amplifikation af polynukleotidsekvenser
ATE317916T1 (de) Verfahren zur identifizierung von adeno- assoziiertem virus (aav) sequenzen sowie kit zur ausführung der methode
DK1159453T3 (da) Fremgangsmåde til direkte nukleinsyresekventering
DK1423400T4 (da) Evolution af hidtil ukendt molekylfunktion
DK1507002T3 (da) Termostabilt Taq-polymerasefragment
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
DE60143314D1 (de) Estimmung der präsenz von cryptosporidium organismen in einer testprobe
ATE427362T1 (de) Polymorphe marker des lsr-gens
ATE554164T1 (de) Primer für nukleinsäureamplifikation bei der detektion von haushaltsgen-mrna und testverfahren unter verwendung der primer
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
EP2180051A3 (en) Method for detecting and quantifying endogenous wheat DNA sequence
ATE414905T1 (de) Diabetesmodell
NO20000537D0 (no) Oligonukleotidprimere for effektiv reverstranskripsjon av Hepatitis C-virus (HCV) RNA og metoder for anvendelse derav
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis
IL195194A0 (en) Thermostable dna polymerase of the archaeal ampullavirus abv and its applications
ATE440153T1 (de) Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie